NMRA-511, a Novel Vasopressin 1a (V1a) Receptor Antagonist Reduces Threat Behaviors in Marmosets and Alters EEG Power Spectra Similarly in Marmosets and Humans

被引：0
|
作者：
Wallace, Tanya [1 ]
Morrison, Filomene [1 ]
Gerrard, Philip [1 ]
Ereshefsky, Larry [1 ]
Ballard, Michael [1 ]
Posener, Joel [1 ]
Tracy, Katherine [1 ]
Tiller, Jane [1 ]
机构：
[1] Neumora Therapeut, Brisbane, CA USA
来源：
NEUROPSYCHOPHARMACOLOGY | 2022年 / 47卷
关键词：
Vasopressin 1a Receptor Antagonist; EEG Biomarkers; Anxiety; Translational Neuroscience;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
P469
引用
收藏
页码：334 / 334
页数：1
相关论文
共 6 条
  • [1] NMRA-511, a Novel Vasopressin 1a (V1a) Receptor Antagonist Reduces Threat Behaviors in Marmosets and Alters EEG Power Spectra Similarly in Marmosets and Humans
    Wallace, Tanya
    Morrison, Filomene
    Gerrard, Philip
    Ereshefsky, Larry
    Ballard, Michael
    Posener, Joel
    Tracy, Katherine
    Tiller, Jane
    NEUROPSYCHOPHARMACOLOGY, 2022, 47 (SUPPL 1) : 334 - 334
  • [2] Vasopressin 1A (V1A) Receptor Antagonists Reduce Anxiety in Marmosets
    Wallace, Tanya
    Steinfeld, Tod
    Poffe, Alessandro
    Pavoni, Valentina
    Gerrard, Philip A.
    Martin, William J.
    BIOLOGICAL PSYCHIATRY, 2020, 87 (09) : S239 - S239
  • [3] Effects of SRX246, a Vasopressin 1a Receptor (V1a) Antagonist, on an Experimental Model of Phasic and Sustained Threat in Humans
    Lago, Tiffany
    Brownstein, Michael
    Beydler, Emily
    Manbeck, Adrienne
    Beale, Alexis
    Simon, Neal
    Ernst, Monique
    Grillon, Christian
    BIOLOGICAL PSYCHIATRY, 2020, 87 (09) : S167 - S168
  • [4] Effects of SRX246, a Vasopressin Receptor (V1a) Antagonist, on an Experimental Model of Phasic and Sustained Threat in Humans
    Lago, Tiffany
    Brownstein, Michael
    Beydler, Emily
    Manbeck, Adrienne
    Beale, Alexis
    Simon, Neal
    Grillon, Christian
    Ernst, Monique
    NEUROPSYCHOPHARMACOLOGY, 2019, 44 (SUPPL 1) : 394 - 394
  • [5] The novel vasopressin receptor (V1aR) antagonist SRX246 reduces anxiety in an experimental model in humans: a randomized proof-of-concept study
    Lago, Tiffany R.
    Brownstein, Michael J.
    Page, Emily
    Beydler, Emily
    Manbeck, Adrienne
    Beale, Alexis
    Roberts, Camille
    Balderston, Nicholas
    Damiano, Eve
    Pineles, Suzanne L.
    Simon, Neal
    Ernst, Monique
    Grillon, Christian
    PSYCHOPHARMACOLOGY, 2021, 238 (09) : 2393 - 2403
  • [6] The novel vasopressin receptor (V1aR) antagonist SRX246 reduces anxiety in an experimental model in humans: a randomized proof-of-concept study
    Tiffany R. Lago
    Michael J. Brownstein
    Emily Page
    Emily Beydler
    Adrienne Manbeck
    Alexis Beale
    Camille Roberts
    Nicholas Balderston
    Eve Damiano
    Suzanne L. Pineles
    Neal Simon
    Monique Ernst
    Christian Grillon
    Psychopharmacology, 2021, 238 : 2393 - 2403
1